We are live on !
Find out more
Linden Thomas Advisory Services Portfolio holdings
AUM
$1.26B
Turnover
7.73%
1-Year Est. Return
37.95%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+37.95%
3 Year Est. Return
+148.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
+$19.2M
(+1.6%)
Cap. Flow
+$30.9M
Cap. Flow % of AUM
Cap. Flow %
2.46%
Top 10 Holdings %
Top 10 Hldgs %
15.07%
Holding
569
New
27
Increased
317
Reduced
206
Closed
17
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.22M |
| 2 |
REX American Resources
REX
|
+$1.81M |
| 3 |
St. Joe Company
JOE
|
+$1.73M |
| 4 |
Cullen/Frost Bankers
CFR
|
+$1.71M |
| 5 |
Preformed Line Products
PLPC
|
+$1.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Catalyst Pharmaceutical
CPRX
|
+$5.53M |
| 2 |
Comfort Systems
FIX
|
+$3.4M |
| 3 |
Ichor Holdings
ICHR
|
+$2.62M |
| 4 |
Select Medical
SEM
|
+$2.19M |
| 5 |
La-Z-Boy
LZB
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.71% |
| 2 | Industrials | 13.48% |
| 3 | Healthcare | 12.55% |
| 4 | Financials | 9.46% |
| 5 | Consumer Discretionary | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$208B
| $4.08M | 0.32% |
27,386
+236
| +0.9% | +$33.1K |
2022 Q4
15 quarters
|
|
77
Kiniksa Pharmaceuticals
KNSA
$7.56B
| $4.06M | 0.32% |
54,401
-402
| -0.7% | -$29.6K |
2023 Q2
13 quarters
|
|
78
AbbVie
ABBV
$521B
| $4.04M | 0.32% |
15,463
+422
| +3% | +$108K |
2022 Q4
15 quarters
|
|
79
Genco Shipping & Trading
GNK
$1.14B
| $4.01M | 0.32% |
153,377
+8,921
| +6% | +$232K |
2023 Q2
13 quarters
|
|
80
T-Mobile US
TMUS
$181B
| $4M | 0.32% |
24,514
+563
| +2% | +$101K |
2022 Q4
15 quarters
|
|
81
Quest Diagnostics
DGX
$28.5B
| $3.99M | 0.32% |
17,102
+4,563
| +36% | +$1.05M |
2022 Q4
15 quarters
|
|
82
PC Connection
CNXN
$2.1B
| $3.97M | 0.32% |
44,006
+20,267
| +85% | +$1.66M |
2026 Q2
1 quarter
|
|
83
CRA International
CRAI
$1.27B
| $3.97M | 0.32% |
24,155
+948
| +4% | +$160K |
2023 Q2
13 quarters
|
|
84
Garmin
GRMN
$54.6B
| $3.96M | 0.31% |
13,804
+141
| +1% | +$39K |
2022 Q4
15 quarters
|
|
85
Corcept Therapeutics
CORT
$7.89B
| $3.96M | 0.31% |
34,326
-315
| -0.9% | -$33.9K |
2023 Q2
13 quarters
|
|
86
Timken Company
TKR
$7.47B
| $3.93M | 0.31% |
33,632
+2,160
| +7% | +$277K |
2023 Q1
14 quarters
|
|
87
SPDR Gold Trust
GLD
$129B
| $3.9M | 0.31% |
10,248
+766
| +8% | +$300K |
2022 Q4
15 quarters
|
|
88
Regeneron Pharmaceuticals
REGN
$99.1B
| $3.88M | 0.31% |
5,113
+7
| +0.1% | +$5.29K |
2022 Q4
15 quarters
|
|
89
Veeva Systems
VEEV
$48.9B
| $3.85M | 0.31% |
13,471
-98
| -0.7% | -$23K |
2022 Q4
15 quarters
|
|
90
Workday
WDAY
$47.3B
| $3.84M | 0.3% |
20,150
+470
| +2% | +$81.9K |
2023 Q3
12 quarters
|
|
91
Merck
MRK
$365B
| $3.72M | 0.3% |
25,571
+465
| +2% | +$64.3K |
2023 Q3
12 quarters
|
|
92
Texas Instruments
TXN
$278B
| $3.71M | 0.29% |
13,232
+296
| +2% | +$81.8K |
2022 Q4
15 quarters
|
|
93
Dorman Products
DORM
$3.91B
| $3.69M | 0.29% |
30,114
+2,403
| +9% | +$318K |
2025 Q2
5 quarters
|
|
94
Netflix
NFLX
$256B
| $3.64M | 0.29% |
52,344
-13,162
| -20% | -$989K |
2022 Q4
15 quarters
|
|
95
Kroger
KR
$41.9B
| $3.62M | 0.29% |
61,718
+766
| +1% | +$44.6K |
2023 Q1
14 quarters
|
|
96
Amgen
AMGN
$252B
| $3.57M | 0.28% |
8,467
+103
| +1% | +$41.1K |
2022 Q4
15 quarters
|
|
97
Allison Transmission
ALSN
$10.4B
| $3.56M | 0.28% |
31,411
+1,671
| +6% | +$202K |
2023 Q1
14 quarters
|
|
98
NRG Energy
NRG
$20.3B
| $3.54M | 0.28% |
37,055
+345
| +0.9% | +$41.6K |
2025 Q2
5 quarters
|
|
99
Applied Industrial Technologies
AIT
$10.9B
| $3.54M | 0.28% |
10,642
+749
| +8% | +$252K |
2023 Q2
13 quarters
|
|
100
Mettler-Toledo International
MTD
$34.5B
| $3.49M | 0.28% |
2,307
+36
| +2% | +$49.6K |
2022 Q4
15 quarters
|
|
Similar funds
Linden Thomas Advisory Services's Q3 2026 Portfolio in Review
As of Q3 2026, Linden Thomas Advisory Services held 569 positions worth $1.26B, up 1.6% from $1.24B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Linden Thomas Advisory Services's Q3 2026 filing shows 27 new, 317 increased, 206 reduced and 17 closed positions. Its largest new stake was REX American Resources: 41,282 shares worth $1.79M. The largest sale was Catalyst Pharmaceutical, an estimated $5.53M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Industrials and Healthcare.
- Linden Thomas Advisory Services's largest Q3 2026 buy was REX American Resources: 41,282 shares worth $1.79M.
- Linden Thomas Advisory Services added most to Amazon in Q3 2026, an estimated $3.22M increase.
- Linden Thomas Advisory Services's biggest Q3 2026 reduction was Comfort Systems, cutting an estimated $3.4M.
- Linden Thomas Advisory Services fully exited Catalyst Pharmaceutical in Q3 2026, selling an estimated $5.53M.
- Linden Thomas Advisory Services's ten largest holdings make up 15% of its $1.26B portfolio in Q3 2026.
- Linden Thomas Advisory Services opened 27 new positions and closed 17 in Q3 2026.
- Linden Thomas Advisory Services's portfolio value rose 1.6% quarter-over-quarter to $1.26B.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.